CLEC16A and adenoma: Six predicted Mir34a targets (Arhgap44, Ccnjl, Clec16a, Esyt3, Golga7b, Grap) were up-regulated in both Mir34a-deficient adenomas and tumoroids (Fig. 7A and B).